| Boceprevir for untreated chronic HCV genotype 1 infection F Poordad, J McCone Jr, BR Bacon, S Bruno, MP Manns, MS Sulkowski, ... New England Journal of Medicine 364 (13), 1195-1206, 2011 | 3383 | 2011 |
| Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening E Quintero, A Castells, L Bujanda, J Cubiella, D Salas, Á Lanas, ... New England Journal of Medicine 366 (8), 697-706, 2012 | 1137 | 2012 |
| Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial. Lancet. 394 (10215), 2184-2196, 2019 | 1082 | 2019 |
| Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients M Romero-Gómez, MDM Viloria, RJ Andrade, J Salmerón, M Diago, ... Gastroenterology 128 (3), 636-641, 2005 | 928 | 2005 |
| Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trial A Parés, L Caballería, J Rodés, M Bruguera, L Rodrigo, A García-Plaza, ... Journal of hepatology 32 (4), 561-566, 2000 | 354 | 2000 |
| Comparison of rifaximin and lactitol in the treatment of acute hepatic encephalopathy: results of a randomized, double-blind, double-dummy, controlled clinical trial A Mas, J Rodés, L Sunyer, L Rodrigo, R Planas, V Vargas, L Castells, ... Journal of hepatology 38 (1), 51-58, 2003 | 347 | 2003 |
| Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication AJ van der Meer, JJ Feld, H Hofer, PL Almasio, V Calvaruso, ... Journal of hepatology 66 (3), 485-493, 2017 | 296 | 2017 |
| Factors that predict response of patients with hepatitis C virus infection to boceprevir F Poordad, JP Bronowicki, SC Gordon, S Zeuzem, IM Jacobson, ... Gastroenterology 143 (3), 608-618. e5, 2012 | 234 | 2012 |
| Effect of sustained virological response to treatment on the incidence of abnormal glucose values in chronic hepatitis C M Romero-Gómez, CM Fernández-Rodríguez, RJ Andrade, M Diago, ... Journal of hepatology 48 (5), 721-727, 2008 | 230 | 2008 |
| Effectiveness, safety and clinical outcomes of direct-acting antiviral therapy in HCV genotype 1 infection: Results from a Spanish real-world cohort JL Calleja, J Crespo, D Rincón, B Ruiz-Antorán, I Fernandez, C Perelló, ... Journal of hepatology 66 (6), 1138-1148, 2017 | 191 | 2017 |
| Treatment of insulin resistance with metformin in naïve genotype 1 chronic hepatitis C patients receiving peginterferon alfa‐2a plus ribavirin M Romero‐Gómez, M Diago, RJ Andrade, JL Calleja, J Salmerón, ... Hepatology 50 (6), 1702-1708, 2009 | 187 | 2009 |
| Long-term safety ofin uteroexposure to anti-TNFα drugs for the treatment of inflammatory bowel disease: Results from the multicenter European TEDDY study M Chaparro, A Verreth, T Lobaton, E Gravito-Soares, M Julsgaard, ... Official journal of the American College of Gastroenterology| ACG 113 (3 …, 2018 | 183 | 2018 |
| NADPH oxidase NOX4 mediates stellate cell activation and hepatocyte cell death during liver fibrosis development P Sancho, J Mainez, E Crosas-Molist, C Roncero, ... Public Library of Science 7 (9), e45285, 2012 | 177 | 2012 |
| Environmental risk factors in inflammatory bowel diseases. Investigating the hygiene hypothesis: a Spanish case–control study P López-Serrano, JL Pérez-Calle, MT Pérez-Fernández, ... Scandinavian journal of gastroenterology 45 (12), 1464-1471, 2010 | 165 | 2010 |
| Development and validation of hepamet fibrosis scoring system–a simple, noninvasive test to identify patients with nonalcoholic fatty liver disease with advanced fibrosis J Ampuero, R Pais, R Aller, R Gallego-Durán, J Crespo, C García-Monzón, ... Clinical Gastroenterology and Hepatology 18 (1), 216-225. e5, 2020 | 154 | 2020 |
| Modifiable endoscopic factors that influence the adenoma detection rate in colorectal cancer screening colonoscopies R Jover, P Zapater, E Polanía, L Bujanda, A Lanas, JA Hermo, J Cubiella, ... Gastrointestinal endoscopy 77 (3), 381-389. e1, 2013 | 142 | 2013 |
| A mesenchymal‐like phenotype and expression of CD44 predict lack of apoptotic response to sorafenib in liver tumor cells J Fernando, A Malfettone, EB Cepeda, R Vilarrasa‐Blasi, E Bertran, ... International journal of cancer 136 (4), E161-E172, 2015 | 141 | 2015 |
| Sofosbuvir/velpatasvir for 12 weeks in hepatitis C virus-infected patients with end-stage renal disease undergoing dialysis SM Borgia, J Dearden, EM Yoshida, SD Shafran, A Brown, Z Ben-Ari, ... Journal of hepatology 71 (4), 660-665, 2019 | 129 | 2019 |
| Metadoxine accelerates fatty liver recovery in alcoholic patients: results of a randomized double-blind, placebo-control trial Journal of Hepatology 28 (1), 54-60, 1998 | 118 | 1998 |
| The effects of metabolic status on non‐alcoholic fatty liver disease‐related outcomes, beyond the presence of obesity J Ampuero, R Aller, R Gallego‐Durán, JM Banales, J Crespo, ... Alimentary pharmacology & therapeutics 48 (11-12), 1260-1270, 2018 | 110 | 2018 |
Moises DiagoProfesor Titular de Medicina在 uv.es 的电子邮件经过验证
